Capital International Investors bought a new stake in Affirm Holdings, Inc. (NASDAQ:AFRM - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,642,528 shares of the company's stock, valued at approximately $100,030,000. Capital International Investors owned approximately 0.52% of Affirm as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in the company. Geneos Wealth Management Inc. increased its position in Affirm by 356.5% during the 4th quarter. Geneos Wealth Management Inc. now owns 525 shares of the company's stock worth $32,000 after purchasing an additional 410 shares during the period. R Squared Ltd purchased a new position in Affirm in the fourth quarter worth $33,000. Strategic Investment Solutions Inc. IL acquired a new stake in Affirm in the fourth quarter valued at $43,000. Creative Financial Designs Inc. ADV boosted its position in shares of Affirm by 640.0% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 740 shares of the company's stock worth $45,000 after purchasing an additional 640 shares in the last quarter. Finally, Prestige Wealth Management Group LLC grew its stake in shares of Affirm by 78.1% during the 4th quarter. Prestige Wealth Management Group LLC now owns 757 shares of the company's stock worth $46,000 after purchasing an additional 332 shares during the period. 69.29% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, Director Keith Rabois sold 16,086 shares of the stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $60.12, for a total value of $967,090.32. Following the completion of the transaction, the director now directly owns 77,608 shares of the company's stock, valued at $4,665,792.96. This represents a 17.17 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Christa S. Quarles sold 5,000 shares of Affirm stock in a transaction on Friday, February 14th. The shares were sold at an average price of $80.00, for a total value of $400,000.00. Following the sale, the director now directly owns 137,325 shares in the company, valued at $10,986,000. The trade was a 3.51 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 55,762 shares of company stock worth $3,241,246 over the last ninety days. 12.41% of the stock is owned by insiders.
Affirm Stock Up 2.9 %
Shares of AFRM stock traded up $1.36 during trading hours on Thursday, reaching $48.20. The company had a trading volume of 7,757,761 shares, compared to its average volume of 8,341,174. The stock's fifty day simple moving average is $50.76 and its 200 day simple moving average is $56.11. The company has a market capitalization of $15.33 billion, a P/E ratio of -74.15 and a beta of 3.68. The company has a debt-to-equity ratio of 2.68, a quick ratio of 11.26 and a current ratio of 11.26. Affirm Holdings, Inc. has a twelve month low of $22.25 and a twelve month high of $82.53.
Affirm (NASDAQ:AFRM - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of ($0.21) by $0.44. Affirm had a negative net margin of 7.10% and a negative return on equity of 7.25%. As a group, sell-side analysts expect that Affirm Holdings, Inc. will post -0.18 earnings per share for the current fiscal year.
Analyst Ratings Changes
AFRM has been the topic of a number of research analyst reports. Seaport Res Ptn raised shares of Affirm to a "hold" rating in a report on Monday, March 24th. Royal Bank of Canada raised their price objective on Affirm from $67.00 to $81.00 and gave the company a "sector perform" rating in a research note on Friday, February 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Affirm in a report on Friday, February 7th. Wells Fargo & Company lowered their target price on Affirm from $85.00 to $67.00 and set an "overweight" rating on the stock in a report on Wednesday, April 9th. Finally, JMP Securities lifted their price target on Affirm from $78.00 to $85.00 and gave the stock a "market outperform" rating in a research note on Friday, February 7th. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $66.74.
View Our Latest Analysis on AFRM
Affirm Profile
(
Free Report)
Affirm Holdings, Inc operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months.
See Also

Before you consider Affirm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Affirm wasn't on the list.
While Affirm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.